Moderna vaccine to be reviewed for WHO emergency listing on April 30 - WHO spokesman

GENEVA - Moderna's COVID-19 vaccine will be reviewed on April 30 by technical experts for possible WHO emergency-use listing, a World Health Organization spokesman told Reuters.

"We are discussing the Moderna COVID-19 vaccine on Friday...," WHO spokesman Christian Lindmeier said in reply to a query. A decision on the U.S. drugmaker's vaccine, now being evaluated under the abridged procedure on the basis of prior review by the European Medicines Agency, was expected in one to four days after that, Lindmeier said. So far COVID-19 vaccines made by Pfizer, AstraZeneca and Johnson & Johnson have received WHO approval, which is a signal to national regulatory authorities on a product's safety and efficacy.